Format

Send to

Choose Destination
Fed Regist. 2007 Mar 6;72(43):9849-52.

Dandruff, seborrheic dermatitis, and psoriasis drug products containing coal tar and menthol for over-the-counter human use; amendment to the monograph. Final rule.

Abstract

The Food and Drug Administration (FDA) is issuing a final rule amending the final monograph (FM) for over-the-counter (OTC) dandruff, seborrheic dermatitis, and psoriasis drug products to include the combination of 1.8 percent coal tar solution and 1.5 percent menthol in a shampoo drug product to control dandruff. FDA did not receive any comments or data in response to its previously proposed rule to include this combination. This final rule is part of FDA's ongoing review of OTC drug products.

PMID:
17447341
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Federal Register
Loading ...
Support Center